Betagenon (private company)
See something wrong or missing? Let us know
Offices:Umeå
Industry:
Biotech
Health services
Pharma
Business model:
B2B
Betagenon is a biopharmaceutical company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat metabolic & cardiorenal and inflammatory disorders associated with obesity and aging.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom